Interestingly, upstream regulator prediction revealed that DEGs in the hippocampus are putative targets of several AD-related proteins, including “TGFB1”, “MAPT”, and “APP”, as well as beta estradiol (P-value < 0.05; Table 2). This evidence concerns the gene APP and Alzheimer disease.